Search by Drug Name or NDC
NDC 59088-0643-54 Dexatran 10; .8; 15; 18; 1; 6.9; 1.3; 30; 5; 6; 200; 10; 18.2 mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 Details
Dexatran 10; .8; 15; 18; 1; 6.9; 1.3; 30; 5; 6; 200; 10; 18.2 mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
Dexatran is a CUTANEOUS; ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PureTek Corporation. The primary component is CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM SULFATE HEPTAHYDRATE; MANGANESE SULFATE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; ZINC SULFATE.
Product Information
| NDC | 59088-0643 |
|---|---|
| Product ID | 59088-643_e052d2c2-7a3e-37be-e053-2a95a90af21c |
| Associated GPIs | |
| GCN Sequence Number | 084893 |
| GCN Sequence Number Description | mv-mins no.73/iron fum/folic CAPSULE 18 MG-1 MG ORAL |
| HIC3 | C6Z |
| HIC3 Description | MULTIVITAMIN PREPARATIONS |
| GCN | 54297 |
| HICL Sequence Number | 049013 |
| HICL Sequence Number Description | MULTIVITAMIN-MINERALS NO.73/FERROUS FUMARATE/FOLIC ACID |
| Brand/Generic | Brand |
| Proprietary Name | Dexatran |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Multivitamin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | CUTANEOUS; ORAL |
| Active Ingredient Strength | 10; .8; 15; 18; 1; 6.9; 1.3; 30; 5; 6; 200; 10; 18.2 |
| Active Ingredient Units | mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 |
| Substance Name | CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM SULFATE HEPTAHYDRATE; MANGANESE SULFATE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; ZINC SULFATE |
| Labeler Name | PureTek Corporation |
| Pharmaceutical Class | Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59088-0643-54 (59088064354)
| NDC Package Code | 59088-643-54 |
|---|---|
| Billing NDC | 59088064354 |
| Package | 30 CAPSULE in 1 BOTTLE, PLASTIC (59088-643-54) |
| Marketing Start Date | 2023-02-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |